Premenstrual Syndrome

Aka: Premenstrual Syndrome, PMS, PMDD, Premenstrual Dysphoric Disorder, Late Luteal Phase Dysphoric Disorder, Premenstrual Disorder

advertisement

II. Epidemiology

  1. Age: Teens may have a higher Prevalence of premenstrual symptoms
  2. Prevalence
    1. Reproductive age women with at least one premenstrual symptom: 90%
    2. Women who have classic premenstrual symptoms: 30-40%
    3. Moderate symptoms (Premenstrual Syndrome): 5-10%
    4. Women who have Premenstrual Dysphoric Disorder: 2-3%
      1. Severe symptoms interfere with work or activities

III. Etiology

  1. Idiopathic
  2. Possible mechanisms
    1. Relative Progesterone deficiency in Luteal Phase
    2. Prostaglandin excess
    3. Cyclic decreases in CNS Dopamine and Serotonin
    4. Premenstrual Estrogen causes Vitamin B6 deficiency
      1. Vitamin B6 is coenzyme for Dopamine and Serotonin
    5. Estrogen-mediated Sodium retention with Fluid Shifts
    6. Increased luteal-phase Insulin to oral Carbohydrates

IV. Symptoms

  1. Timing
    1. Symptom onset 2-12 days before Menses
    2. Symptoms subside with onset of Menses
  2. Somatic or Physical Symptoms
    1. Abdominal Bloating
    2. Breast Pain, tenderness or swelling
    3. Headache
    4. Arthralgias or myalgias
    5. Edema
    6. Weight gain
  3. Affective or Psychological Symptoms
    1. Anxiety
    2. Irritability
    3. Aggression (e.g. angry outbursts)
    4. Depression with Wide mood swings
    5. Social withdrawal
    6. Other symptoms included in DSM5 Criteria (see below)
      1. Increased appetite
      2. Lethargy or Fatigue
      3. Forgetfulness or Reduced concentration
      4. Sleep Disorders (Insomnia or Hypersomnia)

V. History

  1. Consider office Psychiatric Exam during Follicular Phase
  2. Complete medical history
  3. Assess nutritional status
  4. Comorbid factors
    1. Alcohol Abuse
    2. Drug Abuse
    3. Domestic Abuse
  5. Assess functional Impairment

VI. Diagnosis: Premenstrual Syndrome (ACOG)

  1. Consider keeping Daily Symptom Diary for 3 cycles
  2. At least one symptom from the affective and somatic symptoms (see above)
    1. Abdominal Bloating, Breast Pain, Headache, Arthralgias, myalgias, edema or weight gain
    2. Anxiety, irritability, aggression, depression or social withdrawal
  3. Symptoms present in each Menstrual Cycle (record which symptom is most distressing)
  4. Symptoms onset after day 13 of the cycle (at or after Ovulation)
  5. Symptoms resolve within 4 days of Menses onset
  6. Symptoms not due to to other causes (medications, hormonal therapy, drug or alchohol use)
  7. Impaired performance socially, academically or in the work place

VII. Diagnosis: Premenstrual Dysphoric Disorder (DSM 5)

  1. Timing
    1. At least 5 symptoms present in the final week before Menses onset
    2. Symptoms start to improve within days of Menses onset and are minimal or absent by day 7 of cycle
    3. Symptom pattern persists for most of the Menstrual Cycles occurring in the prior year
    4. Symptom pattern should be confirmed on daily symptom diary kept for at least 2 months
  2. Major symptoms (at least one must be present)
    1. Marked mood lability or mood swings
    2. Marked irritability or anger
    3. Marked depressed mood, hopelessness or self deprication
    4. Marked anxiety or tension
  3. Minor symptoms (must total at least 5 symptoms present when added to major symptoms)
    1. Decreased interest in usual activities
    2. Diminished concentration
    3. Lethargy or Fatigue
    4. Appetite change, over-eating or food cravings
    5. Insomnia or Hypersomnia
    6. Overwhelmed or out of control Sensation
    7. Physical symptoms (e.g. Breast tenderness, Arthralgias, myalgias, bloating, weight gain)
  4. Severity
    1. Significant distress or impaired relationships or performance socially, academically or in the work place
  5. Not due to other condition
    1. Not due to Major Depression, Panic Disorder, Dysthymia or Personality Disorder (conditions may however overlap)
    2. Not due to substance use (hormonal agents or other medications, Alcohol or Drugs of Abuse)
    3. Not due to medical condition (e.g. Hypothyroidism, Anemia, Migraine Headache, Endometriosis)
  6. References
    1. (2013) DSM 5, APA, Washington, DC, p. 171-2

VIII. Differential Diagnosis

  1. Mood Disorder (Major Depression, Anxiety)
  2. Eating Disorder (Anorexia Nervosa, Bulimia)
  3. Substance Abuse
  4. Anemia
  5. Migraine Headache
  6. Hypothyroidism
  7. Endometriosis
  8. Perimenopause
  9. Oral Contraceptive adverse effects

IX. Management Algorithm

  1. Step 0
    1. Confirm diagnosis
    2. Daily symptom diary
  2. Step 1: Lifestyle modification (50% response - although no evidence to support benefit)
    1. Dietary changes
      1. Low Fat Diet
      2. Low salt diet (may decrease bloating)
      3. Decrease simple Carbohydrate intake
      4. Avoid Caffeine
      5. Avoid Alcohol
      6. Calcium Supplementation 1200 mg daily
        1. May improve mood, water retention and pain (limited evidence)
        2. Shobeiri (2017) Obstet Gynecol Sci 60(1):100-5 +PMID: 28217679 [PubMed]
    2. Moderate regular Exercise
      1. May decrease anxiety, anger, pain, Constipation and Breast sensitivity
      2. Aerobic Exercise
      3. Strength Training
      4. Yoga or pilates
    3. Bright Light Therapy (10k Lx cool-white fluorescent)
    4. Get adequate sleep per night (see Sleep Hygiene)
    5. Other measures
      1. NSAIDs as needed (with food or milk)
      2. Relaxation Techniques
      3. Anger Management
      4. Individual and family therapy
      5. Self-help support group
      6. Acupuncture
      7. Chasteberry (Vitex agnus-castus)
        1. May improve premenstrual symptoms
        2. Csupor (2019) Complement Ther Med 47:102190 +PMID: 31780016 [PubMed]
  3. Step 2: Antidepressant Trial (SSRI or SNRI)
    1. Precautions
      1. SSRI use in teens may be associated with increased Suicidal Ideation and behavior (RR 2)
    2. Timing
      1. Typically used as continuous daily dosing
      2. Consider instead, Luteal Phase dosing only
        1. Days 17-28 or starting 14 days before anticipated Menses (and continue for 3 days after)
        2. Base starting dose timing on symptom diary
    3. Citalopram (Celexa) or Escitalopram (Levapro)
    4. Fluoxetine (Prozac)
      1. Daily: 20-40 mg qAM OR
      2. Cyclic: 20 mg qd for last 12 days of cycle
    5. Sertraline (Zoloft) 50-100 mg qd
    6. Paroxetine (Paxil) 10-20 mg qd
      1. Avoid without adequate Contraception
    7. References
      1. Dimmock (2000) Lancet 356:1131-6 [PubMed]
      2. Halbreich (2002) Obstet Gynecol 100:1219-29 [PubMed]
  4. Step 3: Oral Contraceptive pill (OCP) trial
    1. OCPs suppress Ovulation and the associated Estrogen and Progesterone fluctuations
      1. Consider Seasonal Contraception
      2. Not uniformly effective in all women with Premenstrual Disorders
    2. Benefit appears to be due to Estrogen component with adjunctive benefit from Drosperinone (Spironolactone analogue)
      1. Monophasic pills may be most appropriate
      2. Yasmin improves mood and physical symptoms
  5. Step 4: Dietary Supplementation trial for 3 months
    1. Calcium Carbonate 1200 mg per day throughout cycle
      1. Thys-Jacobs (1998) Am J Obstet Gynecol 179:444-52 [PubMed]
      2. Ghanbari (2009) Taiwan J Obstet Gynecol 48(2): 124-9 [PubMed]
    2. Vitamin B6 (Pyridoxine) 100 mg daily throughout cycle
      1. Needs confirmation with larger studies
      2. Kashanian (2007) Int J Gynaecol Obstet 96(1): 43-4 [PubMed]
      3. Wyatt (1999) BMJ 318:1375-81 [PubMed]
    3. Other agents with insufficient or variable evidence
      1. Vitamin E 400 to 600 IU daily throughout cycle
        1. May decrease PMS symptoms (esp. Breast tenderness)
      2. Vitamin D Supplementation
        1. Variable evidence
        2. Bertone-Johnson (2014) BMC Womens Health 14:56 [PubMed]
      3. Chasteberry
        1. May improve irritability, mood swings, Breast tenderness, Constipation
      4. Magnesium 360 mg/day (variable evidence)
    4. Avoid supplements found not to be efficacious
      1. Black Cohosh
      2. Dong Quai
      3. Evening Primrose Oil
      4. Progesterone
      5. Red Clover
      6. Vitamin A
      7. Soy products
  6. Step 5: Cognitive Behavioral Therapy
    1. May improve anxiety, depression, negative behaviors, daily life impact and overall premenstrual symptoms
    2. Lustyk (2009) Arch Womens Ment Health 12(2): 85-96 [PubMed]
  7. Step 6: Consider Symptom directed medication
    1. Dysphoria with bloating
      1. Spironolactone 25-100 mg/day during Luteal Phase
      2. Thiazide Diuretics have not shown benefit
    2. Breast Tenderness
      1. See Mastalgia
      2. Oral Contraceptives
      3. Danazol 100 mg bid up to 6 cycles
        1. Risk of masculinization, abnormal LFTs and Lipids
    3. Dysmenorrhea or Menorrhagia: NSAIDS
      1. Mefenamic Acid (Ponstel)
      2. NaproxenSodium (Anaprox)
    4. Headaches and Premenstrual Migraines
      1. NSAIDS
      2. Estradiol patch 0.5 - 0.1 mid-cycle to Menses
  8. Step 7: Anxiolytic trial
    1. Second-line agents for failed SSRI trial
    2. Buspirone
      1. Daily: 5-20 mg qd throughout cycle OR
      2. Cyclic: 5-20 mg qd for last 12 days of cycle
    3. Benzodiazepines
      1. Addictive potential (use only for refractory cases)
      2. NOT recommended
      3. Clonazepam 0.5 mg qhs to tid on premenstrual days
  9. Step 8: Pharmacologic Ovarian Suppression
    1. GnRH Agonist (very expensive: $500 per month)
      1. Leuprolide (Depo Lupron) 3.75 mg IM monthly or
      2. Leuprolide (Depo Lupron) 11.25 mg IM q3 months or
      3. Goserelin (Zoladex) 3.6 mg SQ qMonth or
      4. Goserelin (Zoladex) 10.8 mg SQ q3 months or
      5. Nafarelin (Synarel) 200 to 400 mcg intranasal bid
    2. Concurrently add back Estrogen Replacement
      1. Indicated if GnRH Agonist used for >6 months
      2. Option 1: Topical
        1. Estradiol 1.5 mg topical daily
        2. Progesterone 400 mg Luteal Phase vaginally
      3. Option 2: Systemic
        1. Estrogen (Premarin) 6.25 mg orally daily and
        2. Provera 2.5 mg orally daily if intact Uterus
  10. Step 9: Consider Oophorectomy
    1. Consider in severe, refractory symptoms despite GnRH Agonists

X. References

  1. Ransom (1998) Physician and Sportsmed 26(4):35-43
  2. Rapkin (1999) Fam Pract Recert 21(1):42-73
  3. (2023) Obstet Gynecol 142(6):1516-33 +PMID: 37973069 [PubMed]
  4. (2000) Obstet Gynecol 95:1-9 [PubMed]
  5. Bhatia (2002) Am Fam Physician 66:1239-54 [PubMed]
  6. Biggs (2011) Am Fam Physician 84(8): 918-24 [PubMed]
  7. Daugherty (1998) Am Fam Physician 58(1):183-92 [PubMed]
  8. Dickerson (2003) Am Fam Physician 67(8):1743-52 [PubMed]
  9. Hofmeister (2016) Am Fam Physician 94(3): 236-40 [PubMed]

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Premenstrual Syndrome." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Related Studies

Ontology: late; luteal phase, dysphoric disorder (C0023100)

Concepts Mental or Behavioral Dysfunction (T048)
English late; luteal phase, dysphoric disorder
Dutch laat; luteale fase, dysforische aandoening
Derived from the NIH UMLS (Unified Medical Language System)

Ontology: Premenstrual syndrome (C0033046)

Definition (MEDLINEPLUS)

Premenstrual syndrome, or PMS, is a group of symptoms that start one to two weeks before your period. Most women have at least some symptoms of PMS, and the symptoms go away after their periods start. For some women, the symptoms are severe enough to interfere with their lives. They have a type of PMS called premenstrual dysphoric disorder, or PMDD.

Common PMS symptoms include

  • Breast swelling and tenderness
  • Acne
  • Bloating and weight gain
  • Pain - headache or joint pain
  • Food cravings
  • Irritability, mood swings, crying spells, depression

No one knows what causes PMS, but hormonal changes trigger the symptoms. No single PMS treatment works for everyone. Over-the-counter pain relievers such as ibuprofen, aspirin or naproxen may help ease cramps, headaches, backaches and breast tenderness. Exercising, getting enough sleep, and avoiding salt, caffeine, and alcohol can also help.

Dept. of Health and Human Services Office on Women's Health
Definition (MSH) A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
Definition (PSY) Physiological, emotional, and mental stress related to the period of time immediately preceding menstruation.
Definition (CSP) occurs in some women prior to menstruation; salt and water retention cause weight gain and bloating; individuals may experience mood changes.
Concepts Disease or Syndrome (T047)
MSH D011293
SnomedCT 91055007, 82639001
LNC LA14296-0
English Premenstrual Syndrome, Premenstrual Syndromes, Syndrome, Premenstrual, Syndromes, Premenstrual, PREMENSTRUAL SYNDROME, premenstrual syndrome, premenstrual syndromes, premenstrual syndromes (diagnosis), Syndrome premenstrual, Premenstrual Syndrome [Disease/Finding], premenstrual syndrome (PMS), pms premenstrual syndrome, Menstrual molimen (disorder), Premenstrual syndrome - PMS, Menstrual molimen, PMS, PMS - Premenstrual syndrome, Premenstrual syndrome
French SYNDROME PREMENSTRUEL, SPM, Syndrome prémenstruel
German PRAEMENSTRUELLES SYNDROM, PMS, Syndrom praemenstruell, praemenstruelles Syndrom, Prämenstruelles Syndrom
Dutch syndroom premenstrueel, premenstrueel syndroom, PMS, Premenstrueel syndroom
Portuguese Síndrome premenstrual, SINDROME PREMENSTRUAL, SPM, Síndrome pré-menstrual, Síndrome Pré-Menstrual
Japanese 月経前症候群, ＰＭＳ, ｹﾞｯｹｲﾏｴｼｮｳｺｳｸﾞﾝ, ｹﾞｯｹｲｾﾞﾝｼｮｳｺｳｸﾞﾝ, PMS
Swedish Premenstruellt syndrom
Czech premenstruační syndrom, Premenstruační syndrom, PMS
Finnish Kuukautisia edeltävä oireyhtymä
Russian PREDMENSTRUAL'NYI SINDROM, ПРЕДМЕНСТРУАЛЬНЫЙ СИНДРОМ
Spanish PREMENSTRUAL, SINDROME, TPM, síndrome premenstrual (concepto no activo), síndrome premenstrual, molimen menstrual, SPM, Síndrome premenstrual, Síndrome Premenstrual
Croatian PREMENSTRUACIJSKI SINDROM
Polish Zespół napięcia przedmiesiączkowego
Hungarian PMS, Praemenstruatiós syndroma, Praemenstrualis syndroma
Norwegian PMS, Premenstruelt syndrom
Italian Sindrome premestruale
Derived from the NIH UMLS (Unified Medical Language System)

Ontology: Premenstrual Dysphoric Disorder (C0520676)

Definition (MSH) A condition in which a woman suffers from severe depression, irritability, and tension before MENSTRUATION. Premenstrual dysphoric disorder (PMDD) may involve a wide range of physical or emotional symptoms, which are more severe and debilitating than those seen with premenstrual syndrome (PMS), and which include at least one mood-related symptom. Symptoms usually stop when, or shortly after, menstruation begins.
Definition (PSY) A more severe and disabling form of premenstrual syndrome in which mood symptoms are the primary characteristic.
Concepts Mental or Behavioral Dysfunction (T048)
MSH D065446
ICD10 N94.3
SnomedCT 596004
English PMDD, disorder dysphoric premenstrual, pmdd, premenstrual dysphoric disorder (diagnosis), premenstrual disorder, premenstrual dysphoric disorder, Dysphoric Disorder, Premenstrual, Premenstrual Dysphoric Disorder, Premenstrual Dysphoric Syndrome, Syndrome, Premenstrual Dysphoric, Disorder, Premenstrual Dysphoric, Premenstrual dysphoric disorder, Premenstrual dysphoric disorder (disorder)
Czech Premenstruační dysforická porucha
Dutch premenstruele dysfore stoornis
French Trouble dysphorique prémenstruel
German praemenstruelle Dysphorie
Hungarian Praemenstrualis dysphoriás betegség
Italian Disturbo disforico premestruale
Japanese ｹﾞｯｹｲｾﾞﾝﾌｶｲｷﾌﾞﾝｼｮｳｶﾞｲ, ｹﾞｯｹｲﾏｴﾌｶｲｷﾌﾞﾝｼｮｳｶﾞｲ, 月経前不快気分障害
Portuguese Perturbação disfórica pré-menstrual
Spanish Trastorno disfórico premenstrual, trastorno disfórico premenstrual (trastorno), trastorno disfórico premenstrual
Derived from the NIH UMLS (Unified Medical Language System)

Related Topics in Mental Health

advertisement

2025 Family Practice Notebook, LLC. Terms | Privacy | About | Site Map | Newsletter | Blog

Footer Site Logo